Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir

被引:58
作者
Baz, Mariana
Abed, Yacine
Boivin, Guy
机构
[1] Univ Laval, Quebec City, PQ, Canada
[2] CHUQ, CHUL, Res Ctr Infect Dis, Quebec City, PQ, Canada
关键词
influenza; neuraminidase inhibitors; resistance;
D O I
10.1016/j.antiviral.2006.10.012
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There is a limited information with regard to the neuraminidase (NA) mutations conferring resistance to peramivir and zanamivir in the influenza N1 background. In this study, an influenza A/WSN/33 (H1N1) recombinant virus was passaged under peramivir or zanamivir pressure. The peramivir-selected variant had a H274Y mutation in the neuraminidase (NA) gene conferring resistance to perarnivir and oseltamivir but susceptibility to zanamivir. The zanamivir-selected variant had a massive deletion in the region encoding the NA active center and an A200T hemagglutinin mutation. This variant exhibited reduced susceptibility to zanamivir with a drug-dependent phenotype. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:159 / 162
页数:4
相关论文
共 32 条
  • [1] Abed Y, 2004, ANTIVIR THER, V9, P577
  • [2] BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design
    Babu, YS
    Chand, P
    Bantia, S
    Kotian, P
    Dehghani, A
    El-Kattan, Y
    Lin, TH
    Hutchison, TL
    Elliott, AJ
    Parker, CD
    Ananth, SL
    Horn, LL
    Laver, GW
    Montgomery, JA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (19) : 3482 - 3486
  • [3] Anti-influenza virus activity of peramivir in mice with single intramuscular injection
    Bantia, S
    Arnold, CS
    Parker, CD
    Upshaw, R
    Chand, P
    [J]. ANTIVIRAL RESEARCH, 2006, 69 (01) : 39 - 45
  • [4] In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir
    Barnett, JM
    Cadman, A
    Burrell, FM
    Madar, SH
    Lewis, AP
    Tisdale, M
    Bethell, R
    [J]. VIROLOGY, 1999, 265 (02) : 286 - 295
  • [5] A point mutation in influenza B neuraminidase confers resistance to peramivir and loss of slow binding
    Baum, EZ
    Wagaman, PC
    Ly, L
    Turchi, I
    Le, JH
    Bucher, D
    Bush, K
    [J]. ANTIVIRAL RESEARCH, 2003, 59 (01) : 13 - 22
  • [6] Generation and characterization of an influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en
    Blick, TJ
    Tiong, T
    Sahasrabudhe, A
    Varghese, JN
    Colman, PM
    Hart, GJ
    Bethell, RC
    McKimmBreschkin, JL
    [J]. VIROLOGY, 1995, 214 (02) : 475 - 484
  • [7] SEQUENCE AND STRUCTURE ALIGNMENT OF PARAMYXOVIRUS HEMAGGLUTININ-NEURAMINIDASE WITH INFLUENZA-VIRUS NEURAMINIDASE
    COLMAN, PM
    HOYNE, PA
    LAWRENCE, MC
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (06) : 2972 - 2980
  • [8] Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
    Gubareva, LV
    [J]. VIRUS RESEARCH, 2004, 103 (1-2) : 199 - 203
  • [9] Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en
    Gubareva, LV
    Robinson, MJ
    Bethell, RC
    Webster, RG
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (05) : 3385 - 3390
  • [10] Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en
    Gubareva, LV
    Bethell, R
    Hart, GJ
    Murti, KG
    Penn, CR
    Webster, RG
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (03) : 1818 - 1827